{"id":"NCT00286455","sponsor":"Takeda","briefTitle":"Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of SYR110322 (SYR-322) Compared With Placebo in Subjects With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-02","primaryCompletion":"2007-07","completion":"2007-07","firstPosted":"2006-02-03","resultsPosted":"2011-08-29","lastUpdate":"2012-02-03"},"enrollment":329,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Alogliptin","otherNames":["SYR110322","SYR-322"]},{"type":"DRUG","name":"Alogliptin","otherNames":["SYR110322","SYR-322"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Alogliptin 12.5 mg QD","type":"EXPERIMENTAL"},{"label":"Alogliptin 25 mg QD","type":"EXPERIMENTAL"},{"label":"Placebo QD","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of alogliptin, once daily (QD), in adults with type 2 diabetes.","primaryOutcome":{"measure":"Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 26.","timeFrame":"Baseline and Week 26.","effectByArm":[{"arm":"Placebo QD","deltaMin":-0.02,"sd":0.094},{"arm":"Alogliptin 12.5 mg QD","deltaMin":-0.56,"sd":0.065},{"arm":"Alogliptin 25 mg QD","deltaMin":-0.59,"sd":0.066}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":15,"exclusionCount":14},"locations":{"siteCount":67,"countries":["United States","Argentina","Australia","Brazil","Chile","Czechia","Dominican Republic","Germany","Guatemala","Hungary","India","Mexico","Netherlands","New Zealand","Peru","Poland","South Africa","United Kingdom"]},"refs":{"pmids":["18809631","19793357"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":64},"commonTop":["Nasopharyngitis","Headache","Upper respiratory tract infection","Urinary tract infection","Back pain"]}}